{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:09:49Z","timestamp":1789157389776,"version":"build-2803163510"},"reference-count":7,"publisher":"Association of Biomolecular Resource Facilities","issue":"3","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Academic biomedical research institutions are confronting a converging challenge: tightening federal research budgets and growing demands for faster and more reproducible science,1 and increasing pressure to maximize value derived from every research dollar. Traditional shared resources have enabled access to sophisticated technologies and expertise as transactional, fee-for-service facilities that prioritize throughput and cost recovery over scientific outcomes. We propose a shift toward a Contract Research Organization (CRO)-inspired operating model in which shared resources function as integrated research partners, supported by agentic artificial intelligence (AI) systems that enhance project management, experimental execution, data analysis, and scientific decision-making. This Perspective outlines the limitations of the current paradigm, identifies lessons from commercial CROs, explores the opportunities for agentic AI across major research domains, and presents a roadmap for institutional implementation. We argue that institutions that embrace this transformation will be better positioned to increase productivity, improve reproducibility, accelerate discovery, and strengthen research competitiveness in an increasingly resource-constrained environment.<\/jats:p>","DOI":"10.7171\/001c.167753","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:34:22Z","timestamp":1789155262000},"source":"Crossref","is-referenced-by-count":0,"title":["From Core Facility to Collaborative Partner: Reimagining Institutional Shared Resources as CRO-Model Research Partners Enhanced by Agentic AI"],"prefix":"10.7171","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4600-1132","authenticated-orcid":false,"given":"Jay W.","family":"Fox","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0153tk833","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Virginia","department":["Department of Microbiology, Immunology and Cancer Biology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Nicholas P.","family":"Ambulos","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01vft3j45","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center","department":["Genomics"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4185","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"3","key":"ref1","first-page":"3359","article-title":"The strain on biomedical research funding","volume":"34","author":"V. S. Rolston","year":"2020","journal-title":"FASEB J"},{"issue":"18","key":"ref2","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1073\/iti1815112","article-title":"In this issue","volume":"112","author":"M. Lauer","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7391","key":"ref3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/483531a","article-title":"Drug development: raise standards for preclinical cancer research","volume":"483","author":"C. G. Begley","year":"2012","journal-title":"Nature"},{"issue":"9","key":"ref4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrd3439-c1","article-title":"Believe it or not: how much can we rely on published data on potential drug targets?","volume":"10","author":"F. Prinz","year":"2011","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"ref5","doi-asserted-by":"publisher","first-page":"186345","DOI":"10.1007\/s11704-024-40231-1","article-title":"A survey on large language model-based autonomous agents","volume":"18","author":"L. Wang","year":"2024","journal-title":"Front Comput Sci"},{"issue":"4","key":"ref6","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3934\/publichealth.2022045","article-title":"Artificial intelligence, human intelligence, and the future of public health","volume":"9","author":"S. Bhattacharya","year":"2022","journal-title":"AIMS Public Health"},{"key":"ref7","article-title":"Advanced Notice of Coming Requirements for Formal Instruction in Rigorous Experimental Design and Transparency to Enhance Reproducibility","author":"National Institutes of Health","year":"2015"}],"container-title":["Journal of Biomolecular Techniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jbt.abrf.org\/article\/167753-from-core-facility-to-collaborative-partner-reimagining-institutional-shared-resources-as-cro-model-research-partners-enhanced-by-agentic-ai","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:34:23Z","timestamp":1789155263000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbt.abrf.org\/article\/167753-from-core-facility-to-collaborative-partner-reimagining-institutional-shared-resources-as-cro-model-research-partners-enhanced-by-agentic-ai"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":7,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.7171\/001c.167753","relation":{},"ISSN":["1524-0215"],"issn-type":[{"value":"1524-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}